C J Portier

发表

Stochastic simulation of a multistage model of carcinogenesis.

C. D. Sherman, C D Sherman, C J Portier, 1996, Mathematical biosciences.

Simulating failure times when the event of interest is unobservable with emphasis on animal carcinogenicity studies.

A J Bailer, C J Portier, 1987, Computers and biomedical research, an international journal.

Human exposure estimates for phthalates.

L L Needham, M C Kohn, C J Portier, 2000, Environmental health perspectives.

An illustration of dangers of ignoring survival differences in carcinogenic data

A J Bailer, C J Portier, C. Portier, 1988, Journal of applied toxicology : JAT.

Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.

C J Portier, G. Dinse, C. Portier, 1987, Biometrics.

Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.

L Edler, C. D. Sherman, A Kopp-Schneider, 1996, Toxicology and applied pharmacology.

Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls.

C DeRosa, M C Kohn, C J Portier, 1997, Toxicology and applied pharmacology.

The importance of biological realism in dioxin risk assessment models.

M C Kohn, C J Portier, G. Lucier, 1994, Risk analysis : an official publication of the Society for Risk Analysis.

Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.

C J Portier, G. Clark, G. Lucier, 1992, Cancer research.

Testing for increased carcinogenicity using a survival-adjusted quantal response test.

A J Bailer, C J Portier, C. Portier, 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.

W Thormann, C J Portier, C Spadavecchia, 2006, Toxicology and applied pharmacology.

Effects of temperature and air pollutants on cardiovascular and respiratory diseases for males and females older than 65 years of age in Tokyo, July and August 1980-1995.

C J Portier, Chris Portier, C. Portier, 2001, Environmental health perspectives.

Effects of the mechanism of receptor-mediated gene expression on the shape of the dose-response curve.

M C Kohn, C J Portier, M. Kohn, 1993, Risk analysis : an official publication of the Society for Risk Analysis.

Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. II. Rates of metabolism.

C J Portier, F. Parham, C. Portier, 1998, Toxicology and applied pharmacology.

Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments.

D G Hoel, C J Portier, C. Portier, 1986, Cancer research.

Birth and death/differentiation rates of papillomas in mouse skin.

A Kopp-Schneider, C J Portier, A. Kopp-Schneider, 1992, Carcinogenesis.

Carcinoma formation in NMRI mouse skin painting studies is a process suggesting greater than two stages.

A Kopp-Schneider, C J Portier, A. Kopp-Schneider, 1995, Carcinogenesis.

Issues concerning the estimation of the TD50.

D G Hoel, C J Portier, C. Portier, 1987, Risk analysis : an official publication of the Society for Risk Analysis.

Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans.

C J Portier, D. Bell, C. Portier, 1999, Toxicology and applied pharmacology.

Identification of a Cardiac Sodium Channel Insensitive to Synthetic Modulators

C J Portier, C. Portier, M. Mevissen, 2001, Journal of cardiovascular pharmacology and therapeutics.

Biostatistical issues in the design and analysis of animal carcinogenicity experiments.

C J Portier, C. Portier, 1994, Environmental health perspectives.

Two-stage models of carcinogenesis, classification of agents, and design of experiments.

L Edler, C J Portier, C. Portier, 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Nonlinearity of dose-response functions for carcinogenicity.

D G Hoel, C J Portier, C. Portier, 1994, Environmental health perspectives.

Characterizing Dose‐Response I: Critical Assessment of the Benchmark Dose Concept

C J Portier, C. Portier, J A Murrell, 1998, Risk analysis : an official publication of the Society for Risk Analysis.

Reevaluating cancer risk estimates for short-term exposure scenarios.

C J Portier, C. Portier, S. Roberts, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

An evaluation of some methods for fitting dose-response models to quantal-response developmental toxicology data.

C J Portier, G J Carr, C. Portier, 1993, Biometrics.

Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride.

C J Portier, C. Portier, N. Kaplan, 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples.

A J Bailer, C J Portier, C. Portier, 1988, Biometrics.

Design of animal carcinogenicity studies for goodness-of-fit of multistage models.

D G Hoel, C J Portier, C. Portier, 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice.

M C Kohn, C J Portier, R. Melnick, 2001, Toxicology and applied pharmacology.

A multistage model of carcinogenesis incorporating DNA damage and repair.

A Kopp-Schneider, C J Portier, A. Kopp-Schneider, 1991, Risk analysis : an official publication of the Society for Risk Analysis.